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Signaling pathway components mediating Epstein–Barr virus (EBV) reactivation by 12-O-tetradecanoylphorbol-13-acetate (TPA)
were characterized in terms of induction and modification of specific transacting factors. The consequences of protein kinase C
(PKC) activation by TPA in inhibiting inducible nitric oxide synthase (iNOS) mRNA expression were analyzed in the EBV-infected
gastric epithelial cell line GT38. Spontaneous expression of the EBV BZLF1 gene product ZEBRA became undetectable upon
long-term culturing of GT38 cells, while iNOS mRNA expression increased. In such cells the PKC inhibitors 1-(5-isoquinolinesul-
phonyl)-2,5-dimethylpiperazine (H7) and staurosporine inhibited TPA-induced expression of BZLF1 and BRLF1 and reversed
TPA-mediated inhibition of iNOS gene expression. The mitogen-activated protein kinase inhibitor PD98059 inhibited TPA-induced
BZLF1 expression. Electrophoretic mobility shift assays demonstrated that transcription factors NF-kB and AP-1 were also
activated by TPA in a time-dependent manner. The TPA-induced NF-kB activation was inhibited by prior treatment of the cells with
the NF-kB inhibitor pyrrolidine dithiocarbamate (PDTC). TPA-induced BZLF1 expression was also inhibited by the treatment with
PDTC. Northern blot analyses characterized changes in levels of the c-jun and junB expressions of the AP-1 family. These results
show that TPA induces EBV reactivation via NF-kB and AP-1 and that PKC is an important mediator in regulating gene expression
leading to EBV reactivation after TPA treatment of GT38 cells. © 2001 Academic Press
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(INTRODUCTION
Nitric oxide (NO) is a potent second messenger with
diverse physiological activities, including regulation of
vascular tone and neurotransmission, and killing of mi-
croorganisms and tumor cells (Nathan, 1992; Moncada
and Higgs, 1993; Bredt and Snyder, 1994). The inducible
form of nitric oxide synthase (iNOS) in various cell types,
including macrophages, hepatocytes, and astrocytes, is
expressed in response to proinflammatory cytokines and
bacterial lipopolysaccharide (Stuehr and Marlettla, 1985;
Togashi et al., 1997; Wang et al., 1998). Our previous
studies showed that iNOS mRNA is constitutively ex-
pressed in Epstein–Barr virus (EBV)-infected gastric ep-
ithelial cell lines GT38 and GT39 and that NO down-
regulates EBV reactivation in those cells (Gao et al.,
1999).
EBV is a human herpesvirus that infects B cells and
epithelial cells to establish a latent infection (Kieff, 1996).
The latency can be disrupted by certain compounds
including 12-O-tetradecanoylphorbol-13-acetate (TPA)
(zur Hausen et al.,1978; Gao et al., 1999) or by cross-
linking of surface immunoglobulin (Takada, 1984). These
agents activate expression of the viral immediate-early
1 To whom correspondence and reprint requests should be ad-
ressed. Fax: 181-859-34-8042. E-mail: sairen@grape.med.tottori-u.
c.jp.
91protein BZLF1, which is also termed ZEBRA, EB1, Zta, or
Z (Countryman and Miller, 1985; Chevallier-Greco et al.,
1986; Takada et al., 1986). BZLF1 is a viral homolog of the
ellular c-fos transcription factor which binds to AP-1-like
equences termed ZEBRA response elements or ZRE
Farrell et al., 1989; Flemington and Speck, 1990b; Lieber-
man et al., 1990). The BZLF1 promoter region contains
several TPA-responsive binding motifs for transcription
factor such as ATF1, ATF2, and c-Jun (Wang et al.,1997),
as well as ZRE that trigger BZLF1 expression via a
positive feedback mechanism (Flemington and Speck,
1990a; Daibata et al.,1994).
NF-kB constitutively exists as an inactive cytoplasmic
heterotrimeric complex that can be activated by proper
stimuli via a posttranslational phosphorylation mecha-
nism involving several kinases (and without inducing
protein synthesis) leading to the dissociation of NF-kB
rom cytosolic IkB. Such released NF-kB is then able to
ranslocate into the nucleus where it binds to a specific
NA sequence to regulate expression of various genes
Adcock et al., 1994; Xie et al., 1994; Kim et al., 1995).
It is well known that TPA is a potent protein kinase C
(PKC) activator and tumor promoter (Castagna et al.,
1982; Nishizuka, 1984). In a previous paper, we showed
that TPA induces EBV reactivation by inhibiting iNOS
mRNA expression in human gastric epithelial cell lines
(Gao et al., 1999). However, the molecular mechanism of
EBV reactivation was not defined. In the current study,
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92 GAO ET AL.we have characterized in detail the intracellular signaling
pathways by which TPA induces EBV reactivation and
inhibits iNOS expression in human gastric epithelial
cells. We have demonstrated that PKC plays an enhanc-
ing role in EBV reactivation and a suppressing role on
iNOS expression.
RESULTS
iNOS gene and BZLF1 expressions in GT38 cells
The GT38 cell line was an EBV producer, expressing
lytic antigens and producing infectious virus spontane-
ously (Takasaka et al., 1998). However, we showed pre-
viously in those cells that without TPA stimulation neither
BZLF1 mRNA nor the gene product ZEBRA protein was
detectable and concurrently that only a low level of iNOS
mRNA was constitutively expressed (Gao et al., 1999).
We hypothesized that the levels of iNOS expression may
differ among the GT38 cell sublines depending on the
cumulative duration of culture. To investigate whether
endogenous NO regulates spontaneous EBV reactiva-
tion, we examined the levels of iNOS mRNA and ZEBRA
by reverse transcriptase-polymerase chain reaction (RT-
PCR) Southern and Western blotting, respectively, in
GT38 cells cultured for 8 months after being established
(GT38-96), 2 years (GT38-97), or more than 3 years
(GT38-98). These “short-term,” “medium-term,” and “long-
term” cultured sublines offer stable vignettes of varying
levels of gene activation and expression for our studies.
As shown in Fig. 1, the expression of ZEBRA was highest
in GT38-96 cells, and it was much higher in GT38-97
cells than in GT38-98 cells, in which ZEBRA expression
FIG. 1. Expression of iNOS mRNA and ZEBRA in GT38 cells pas-
saged for different times after being established. GT38-96, -97, and -98
cells were passaged for 8 months, 2 years, and more than 3 years,
respectively. Total RNA and protein were extracted from the confluent
cultures, and RT-PCR Southern and Western blot analyses were carried
out as described under Materials and Methods. Equal amounts of each
sample were PCR amplified using primers specific for either iNOS or
tubulin. Equal amounts of proteins were blotted onto the membrane
and reacted with anti-ZEBRA monoclonal antibodies.had almost completely disappeared. In contrast to
ZEBRA, iNOS mRNA expression was highest in GT38-98
t
icells, and it was much higher in GT38-97 cells than in
GT38-96 cells. These results suggest that constitutively
produced NO may inhibit spontaneous EBV reactivation.
GT38-96 cells were used for the following analyses.
Effects of PKC and mitogen-activated protein kinase
(MAPK) inhibitors on EBV immediate-early gene
expression and iNOS mRNA expression
The phorbol ester TPA is well known, a potent activator
of PKC (Nishizuka, 1984). We reported that TPA induces
EBV reactivation from latent state to lytic phase by inhib-
iting iNOS activation (Gao et al., 1999). To analyze
whether PKC and MAPK pathways are involved in the
TPA-induced inhibition of iNOS gene expression and
EBV reactivation, GT38 cells were treated with 1-(5-iso-
quinolinesulphonyl)-2,5-dimethylpiperazine (H7) or stau-
rosporine, which are potent inhibitors of PKC, and
PD98059, which is an inhibitor of MAPK, for 1 h, followed
by TPA for 8 h (Fig. 2). TPA-induced expressions of BZLF1
(3.8-fold increase) and BRLF1 (3.7-fold increase) were
greatly inhibited by prior treatment of the cells with either
H7 (induced BZLF1 59% decrease and BRLF1 55% de-
crease) or staurosporine (induced BZLF1 72% decrease
and BRLF1 50% decrease). PD98059 also inhibited the
induction of BZLF1 by 42% and BRLF1 by 45%, although
its effect appeared to be less than that of either H7 or
staurosporine. On the other hand, TPA markedly inhibited
iNOS mRNA expression by 93.8% and that inhibition
could be reversed by prior treatment of the cells with H7,
staurosporine, or PD98059 (increased 15.9-, 12.2-, and
16.5-fold, respectively, compared with TPA treatment).
Taken together, these results indicated that the PKC and
MAPK pathways mediate TPA-induced EBV reactivation.
Furthermore, PKC and MAPK are principal negative reg-
ulators of iNOS gene expression in TPA-stimulated GT38
cells.
TPA induces NF-kB and AP-1 activation in GT38 cells
To investigate whether TPA induces NF-kB, AP-1, and
P-1 activation in GT38 cells, we performed electro-
horetic mobility gel shift assays (EMSA) for these trans-
cting factors (Fig. 3). NF-kB is composed of 50 and 65
Da subunits (Xie et al., 1994; Thanos and Maniatis,
995; Murono et al., 2000). Two bands were detected
ith the NF-kB probe and were NF-kB subunits in agree-
ment with the previous papers (Fig. 3A). NF-kB binding
ctivity rapidly increased and peaked at 0.5 h after TPA
reatment, thereafter declined to a near-basal level at 2 h
Figs. 3A and 3C). AP-1 followed a similar pattern in the
ntensity of binding activity (Figs. 3B and 3D). TPA treat-
ent further increased the level of activated AP-1 in the
uclear extracts. The binding activity peaked at 0.5 h and
as maintained at a high level until 2 h after TPA addi-ion. The binding activities of NF-kB and AP-1 were
nhibited completely by the each competitor. As the neg-
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93TPA INDUCES EBV REACTIVATION VIA NF-kB AND AP-1ative control, SP-1 binding activity was not detected (data
not shown). These results showed that TPA induces
NF-kB and AP-1 activation with a comparable time-de-
pendent manner.
Pyrrolidine dithiocarbamate (PDTC) inhibits NF-kB
activity and BZLF1 expression
To study further the involvement of NF-kB and AP-1 in
TPA-induced BZLF1 expression, the effect of PDTC, a
potent inhibitor of NF-kB activation, was examined in
T38 cells by EMSA. PDTC was added to the medium 1 h
efore TPA. TPA-induced NF-kB activation was clearly
FIG. 2. The effects of PKC and MAPK inhibitors on TPA-mediated
iNOS mRNA, BRLF1, and BZLF1 expression. (A) GT38 cells were pre-
treated with a PKC inhibitor H7 or staurosporine (St), or a MAPK
inhibitor PD98059 (P9) for 1 h, and then treated with TPA (20 ng/ml) for
8 h. Total RNA was extracted, and Northern and RT-PCR Southern
analyses were performed as described under Materials and Methods.
(B) The autoradiographic signals were quantitated by a phosphorim-
ager system and the relative amounts to tubulin or GAPDH signals
were determined. The data represent three independent experiments,
and the standard errors of the means are shown.inhibited by PDTC treatment (Figs. 4A and 4C). In con-
trast, PDTC treatment did not affect TPA-induced AP-1activation in GT38 cells (data not shown). These results
differed from a previous report of experiments, indicating
that PDTC can enhance the TPA-evoked activation of the
AP-1 factor in HeLa cells (Menegazzi et al., 1996). Fur-
hermore, we determined expression levels of BZLF1 and
RLF1 by Northern blotting (Figs. 4B and 4D). PDTC
ecreased TPA-induced BZLF1 and BRLF1 expressions.
hese results indicated that TPA-induced EBV reactiva-
ion is mediated at least partially through NF-kB and AP-1
pathways in GT38 cells.
Effect of TPA on EBV reactivation and AP-1 family
gene expressions
In EBV-containing lymphoid cell lines, EBV latency can
be disrupted by TPA, whose effects are mediated by the
AP-1 transcription factor c-Fos and c-Jun (Farrell et al.,
1989). To determine which members of the AP-1 family
could be induced by TPA, the gene expressions of AP-1
constituents were examined by Northern blot analyses
(Fig. 5). GT38 cells were incubated without or with TPA
for intervals from 0.5 to 24 h. After TPA stimulation c-Jun
was increased significantly at 0.5 h, reached a peak at
2 h, and declined to a low level at 24 h after stimulation.
The junB was constitutively expressed in TPA-untreated
control cells. After TPA treatment, junB was increased
slightly at 0.5 h, reached a plateau at 1 h, and maintained
a high level at least until 24 h. We failed to detect c-fos
mRNA in TPA-untreated and -treated GT38 cells (data not
shown). The expressions of BRLF1 and BZLF1 were
induced in a time-dependent manner. These results are
consistent with the view that the expressions of c-jun
and junB but not c-fos mediate TPA-induced EBV reacti-
vation.
DISCUSSION
GT38 cell line has been reported as an EBV producer,
expressing lytic antigens and producing infectious virus
spontaneously (Takasaka et al., 1998). We have also
shown that neither BZLF1 mRNA nor ZEBRA was detect-
able without TPA stimulation and NO inhibited TPA-in-
duced EBV reactivation (Gao et al., 1999). In the present
study we showed that the levels of ZEBRA and iNOS
mRNA expression took a reverse order according to the
term of culture of GT38 cells. These results suggested
that NO is able to inhibit not only TPA-induced EBV
reactivation, but also spontaneous EBV reactivation.
In this study, we have investigated the molecular
mechanisms by which TPA inhibits iNOS gene expres-
sion and induces EBV reactivation in the gastric tissue-
derived epithelial cell line GT38 cells. In particular, using
PKC inhibitors, we first demonstrated the involvement of
PKC pathway in TPA-induced EBV reactivation. This ob-
servation has led to a better insight into the signal
transduction pathway associated with EBV reactivation.
In our previous report, we showed that the PKC activator
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94 GAO ET AL.TPA induced EBV immediate-early gene BZLF1 expres-
sion by inhibiting iNOS expression in GT38 cells (Gao et
al., 1999). In extending this observation in the present
tudy we tested the effects of the PKC inhibitors H7 and
taurosporine in those cells, finding the induction of
ZLF1 expression by TPA to be abolished by those in-
ibitors. In contrast to that finding with BZLF1, TPA down-
egulated iNOS expression was reversed by the PKC
nhibitors. Taken together, these results support the view
hat the TPA-induced up-regulation of BZLF1 and down-
egulation of iNOS expression are both mediated by a
KC-associated pathway. These results led us to postu-
ate that potentially produced NO might down-regulate
ZLF1 expression.
The most straightforward explanation for this process
FIG. 3. Time course of NF-kB and AP-1 binding following incubation
g/ml), and then nuclear extracts were prepared at the indicated time
y EMSA. Competitive binding reactions (Comp.) were tested by addi
efore adding the labeled probe. The relative densitometric units of N
he data shown represent three independent experiments, and the sts that PKC primarily down-regulates iNOS gene expres-
ion, resulting in down-regulated NO production, whichin turn leads to increased BZLF1 expression as a rapid
response to TPA. In addition to PKC, we have reported
that MAPK is also an important signal transducer for EBV
reactivation in B cells (Satoh et al., 1998), but its role in
TPA-induced EBV reactivation has remained unclear.
Thus in this study, we further tested for the role of MAPK
in the TPA-induced EBV reactivation. Similar to PKC,
MAPK was shown also to play an inducing role in TPA-
induced EBV reactivation and iNOS gene expression
(Figs. 2 and 4). Interpreting these results with those of
our previous report (Gao et al., 1999), we conclude that
TPA-induced EBV reactivation is mediated by both PKC
and MAPK pathways in which NO play a regulatory key
role.
BZLF1 is a sequence-specific DNA binding protein in
38 cells with TPA. GT38 cells were incubated with or without TPA (20
–protein binding activities of (A) NF-kB and (B) AP-1 were determined
0-fold excess of unlabeled NF-kB or AP-1 oligonucleotide for 30 min
d AP-1 DNA binding activities are shown in (C) and (D), respectively.
errors of the means are shown.of GT
s. DNA
ng a 10the bZip family of transcription factors which transacti-
vate several early lytic-phase viral promoters via cis-
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BZLF1 and BRLF1 were quantitated by a phosphorimage system and the c
represented were compiled from three independent experiments, and the sta
extracted at the indicated times. Northern blottings were performed as
described in Fig. 1.
95TPA INDUCES EBV REACTIVATION VIA NF-kB AND AP-1acting ZRE DNA binding motifs (Urier et al., 1989). BZLF1
ontains a carboxyl-terminal domain that mediates ho-
odimerization through a coiled–coil interaction (Chang
t al., 1990; Kouzarides et al., 1991) and a basic region
hich shares sequence homology with the DNA-binding
omain of members of the AP-1 family of transcription
actor (Farrell et al., 1989; Urier et al., 1989). Hence,
BZLF1 binds to TPA responsive element (TRE) or AP-1
sequence motifs with high affinity (Farrell et al., 1989;
Lieberman et al., 1990). Our results indicate that TPA can
induce AP-1 binding activity in a time-dependent manner,
suggesting the possibility that BZLF1 expression might
be regulated by AP-1. This result is consistent with those
by Borras and co-workers (Borras et al., 1996). In addition
to AP-1, treatment of GT38 cells with TPA, causing BZLF1
expression, also up-regulated NF-kB binding activity that
an be reversed by addition of NF-kB inhibitor PTDC
(Figs. 3 and 4). This suggests that NF-kB is also involved
n the up-regulation of BZLF1 by TPA, and that, excepting
he binding sequence for NF-kB on genomic DNA, the
BZLF1 promoter domain might also contain binding sites
for the transcription factor NF-kB. To determine finally if
. GT38 cells were pretreated with PDTC (100 mM) for 1 h prior to TPA
reatment, and NF-kB DNA–protein binding activity was determined by
lotting for BZLF1 and BRLF1 were carried out as described in Figs. 1
ed by the densitometric analysis. (D) The autoradiographic signals of
orrected scanning ratio to the GAPDH signals is shown. The data
ndard errors of the means are shown.FIG. 4. PDTC inhibits TPA-induced NF-kB activation and BZLF1 expression
(20 ng/ml) treatment. (A) Nuclear extracts were prepared at 30 min after TPA t
EMSA. (B) Total RNA was extracted at 8 h after TPA treatment and Northern b
and 2, respectively. (C) Relative amounts of the NF-kB complex were determinFIG. 5. The effect of TPA on BZLF1, BRLF1, c-jun, and junB expres-
sion. GT38 cells were treated with TPA (20 ng/ml) and total RNAs werethe TPA-induced up-regulation of BZLF1 expression is
regulated by a mechanism involving NF-kB, further ex-
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96 GAO ET AL.periments using BZLF1 promoter elements transfection
assay are needed.
AP-1 transcription factor is a complex composed of
proteins of the fos and jun proto-oncogene families,
which need to dimerize to promote binding of the com-
plex to the AP-1 recognition site (Hunter and Karin, 1992).
Using Northern blot analysis, c-jun and junB mRNA iden-
tified as components of AP-1-DNA neucleoprotein com-
plexes in GT38 cells. Conceivably, regulation of the
BZLF1 and BRLF1 promoters in GT38 cells may be me-
diated, in part, through a homodimer of c-Jun or c-Jun/
JunB heterodimer. c-jun mRNA expression paralleled the
induction of the BZLF1 and BRLF1 genes. It has been
reported that TPA can induce c-Jun N-terminal kinase
(JNK) activity (Okumura et al., 1999). JNK-mediated phos-
phorylation is also required for activation of the c-jun
(Kyriakis et al., 1994). Our results here indicate that TPA
may activate JNK, thereby inducing phosphorylation of
c-Jun, which bind to the ZI and ZII elements of the BZLF1
promoter.
NF-kB and AP-1 were activated constitutively in GT38
cells (Fig. 3). TPA enhanced the NF-kB and AP-1 activi-
ties and induced EBV reactivation. What does this mean
in terms of the maintaining EBV latency and reactivation
from latency ? The latency in GT38 cells is type III, which
expresses EBNA1, EBNA2, and LMP1 (Takasaka et al.,
1998; Murakami et al., 2000). The observed constitutive
activation of NF-kB and AP-1 may be due to the expres-
ion of LMP-1, which evokes activation of the tumor
ecrosis factor (TNF) receptor downstream signaling
athway (Izumi et al., 1997). Cytoplasmic domain of
MP-1 contains two functional domains, namely, CTAR1
nd CTAR2 (Izumi and Kieff, 1997). The ability of CTAR1 to
ctivate NF-kB appears to be attributable to the direct
nteraction of TNF receptor-associated factor 2, and
TAR2-induced NF-kB is mediated through its associa-
ion with TNF receptor-associated death domain (Elio-
oulos et al., 1999). These two functional domains of
MP1 can independently activate NF-kB (Mitchell and
ugden, 1995). In addition to NF-kB, LMP1 signals for
activation of JNK pathway, a phenomenon which is me-
diated through CTAR2 but not CTAR1 and translates the
induction of AP-1 (Kieser et al., 1997; Eliopoulos and
Young, 1998). The constitutive activation of these signal-
ing molecules maintains the EBV latency. When the bal-
ance of activation signal is unbalanced by TPA, the EBV
latency could be disrupted to reactivation. TPA is well
known, a potent activator of PKC, and TPA induced NF-kB
and AP-1 activation (Fig. 3). In the present study, we
address the finding that TPA activates NF-kB and AP-1
inding activity through PKC and/or MAPK pathway, then
nteracts the downstream signaling pathway including
os and jun family gene expression, and reactivates
ZLF1 and BRLF1 expression. However, it remains to be
tudied more how the signaling molecules and pathways
re involved by TPA stimulation.
s
aIn conclusion, our results have for the first time dem-
nstrated that TPA-induced EBV reactivation can occur
y activating NF-kB and AP-1, and we suggest that this
reactivation, marked by BZLF1 expression, is likely to be
mediated at least via both PKC and MAPK pathways in
the gastric tissue-derived epithelial cell line GT38.
MATERIALS AND METHODS
Cell line and reagents
GT38 cells were EBV-positive epithelial cell line de-
rived from a human gastric tissue (Tajima et al., 1998).
The cells were grown in RPMI 1640 medium, supple-
mented with 10% fetal bovine serum, penicillin (100
U/ml), and streptomycin (100 mg/ml), in 60- or 100-mm
ell culture dishes. All cells were incubated in an atmo-
phere of 95% air and 5% CO2. For EBV reactivation, in
ome cases, cells were treated with 20 ng/ml TPA
Sigma Chemical Co., St. Louis, MO). H7, staurosporine,
D98059, and PDTC were purchased from Sigma and
issolved in dimethyl sulfoxide before adding to culture
edium.
reparation of RNA and Northern blot analysis
Total RNA from cultured cells was prepared by an
SOGEN Kit (Nippongene Inc., Tokyo, Japan) according to
he manufacturer’s protocol as described previously
Gao et al., 1999). The RNA was dissolved in diethyl
yrocarbonate-treated water and stored at 220°C. All
NA samples had an OD260/OD280 ratio . 1.50.
Northern blot analysis was carried out by the method
escribed previously (Gao et al., 1999). Aliquots contain-
ng 20 mg of total RNA were loaded into 1% agarose
formaldehyde gels and then transferred to Hy-
bondTM-N1 membranes (Amersham, Buckinghamshire,
.K.) by capillary transfer and UV-autocrosslinked. Mem-
ranes were prehybridized in prehybridization buffer for
h at 42°C, and then hybridized at 42°C for 24 h in the
ame solution with 32P-labeled cDNA probes for BZLF1
r glyceraldehyde-3-phoshate dehydrogenase (GAPDH)
Gao et al., 1999) or c-jun or junB (Wang et al., 1999). The
lots were washed three times at 65°C in 13 SSPE, 0.1%
DS for 10 min. The blots were exposed to Kodak X-AR
ilm (Eastman Kodak Co., Rochester, NY) at 280°C for
–3 days. Relative mRNA levels were quantitated with a
hosphorimaging system (Molecular Imager, Nippon
io-Rad Laboratories, Tokyo, Japan). Each Northern blot
as representative of at least three separate experi-
ents performed at different times, unless otherwise
pecified.
T-PCR analysis
The PCR was performed basically as previously de-
cribed (Gao et al., 1999). The sequences of sense and
ntisense primers used for amplification of specific hu-
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97TPA INDUCES EBV REACTIVATION VIA NF-kB AND AP-1man iNOS cDNA are as follows: sense primer, 59-CTGTC-
CTTGGAAATTTCTGTT-39; antisense primer, 59-GTGATG-
GCCGACCTGATGTTGC-39, to amplify a 729-bp nucleo-
ide product (Gao et al., 1999). The oligonucleotides of
he “housekeeping gene” human b-tubulin (GenBank Ac-
ession No. V00599) were designed as 59-TGGATCTA-
AACCTGGGACCAT-39 (sense primer) and 59-ACCATGT-
GACTGCCAACTTGC-39 (antisense primer) to amplify a
77-bp product (Gao et al., 1999). The amplified PCR
roducts were analyzed after electrophoresis in a 1.2%
garose gel, blot-transferred to HybondTM-N1 mem-
brane, and UV-autocrosslinked. The membranes for
iNOS or tubulin were prehybridized with prehybridization
buffer and then hybridized with the labeled iNOS or
tubulin probes (Gao et al., 1999). The hybridized PCR
product was visualized by autoradiography as for North-
ern blotting described above. Each illustrated RT-PCR
Southern blotting is representative of at least three sep-
arate experiments performed at different times.
Western blot analysis
Western blot analyses were performed as previously
described (Gao et al., 1999). Protein samples (50 mg)
ere separated in 10% SDS–polyacrylamide gel, and
lectrophoretically transferred onto polyvinylidene diflu-
ride membranes (Millipore Co., Bedford, MA), using a
emidry transfer blot system. As confirmed by Coomas-
ie brilliant blue dye, equal amounts of proteins were
lotted onto the membranes, and then the membranes
ere incubated with anti-ZEBRA monoclonal antibodies
developed in our laboratory, 1:500) in blocking buffer.
lots were washed in blocking buffer three times and
hen incubated with the labeled rabbit anti-mouse IgG
ntibodies in the identical blocking buffer for 1 h. The
lots were washed in blocking buffer three times, fol-
owed by the chemiluminescence reaction, and exposed
o X-ray films.
reparation of nuclear extract
Nuclear extracts were obtained from TPA-treated cells
rown to confluence in 100-mm dishes. All extraction
rocedures were performed on ice with ice-cold re-
gents. Cells were washed with phosphate-buffered sa-
ine (PBS), harvested by scraping into 1 ml PBS, and
entrifuged (12,000 rpm, 15 s). The pellet was dispersed
n buffer A containing 10 mM HEPES–KOH (pH 7.6), 10
M KCl, 0.1 mM EDTA, 1 mM dithiothreitol, 1 mM phe-
ylmethylsulfonyl fluoride. After 15 min on ice, Nonidet
-40 was added into the mixture to a final concentration
f 0.6% (v/v), followed by a 10 s vortexing, and then nuclei
ere pelleted by centrifugation (15,000 rpm, 30 s). The
uclei pellet was dispersed in a high salt buffer (contain-
ng 20 mM HEPES–KOH (pH 7.6), 0.4 M NaCl, 1 mM
DTA, 1 mM dithiothreitol, 1 mM phenylmethylsulfonyl
luoride) to solubilize DNA-binding proteins. The sus-ended nuclear pellet was shaken for 15 min on ice and
entrifuged for 5 min at 4°C. The clear supernatant
ontaining nuclear proteins was divided into small ali-
uots and were stored at 280°C.
MSA
Double-stranded synthetic oligonucleotide probes
ontaining the NF-kB consensus sequences (NF-kB, 59-
AGTTGAGGGGACTTTCCCAGGC-39) and the AP-1 con-
sensus sequences (AP-1, 59-CTAGTGATGAGTCAGCCG-
GATC-39) (Chen et al., 1998) (Armersham Pharmacia Bio-
teck, Tokyo, Japan) were used in the EMSA. Forty
nanograms of the double-stranded oligonucleotide were
labeled with [g-32P]ATP using T4-polynucleotide kinase
(Amersham Pharmacia Bioteck) and purified through Mi-
crospinTM G-25 columns (Amersham Pharmacia Bio-
teck).
Samples (10 mg) of nuclear extract and 0.1 ng (10,000
cpm) of double-stranded labeled oligonucleotide were
incubated in DNA binding buffer containing 25 mM
HEPES–KOH (pH 7.9), 40 mM KCl, 0.1 mM EDTA, 7.5%
glycerol, 5 mM MgCl, 2 mg BSA, and 2 mg poly(dI-dC)
(Roche Molecular Biochemicals, Tokyo, Japan) at a final
volume of 10 ml. The binding reaction was performed at
°C for 30 min. Competition experiments were per-
ormed by adding a 100-fold excess of unlabeled self
ouble-stranded oligonucleotide before the labeled
robes. DNA–protein complexes were analyzed by elec-
rophoresis on 5% polyacrylamide gels in Tris–glycine
uffer (50 mM Tris, 380 mM glycine, 2mM EDTA, pH 8.2).
lectrophoresis was run at 4°C at 130 V for 3 h under
ondenaturing conditions. Gels were dried and exposed
o X-ray films at 280°C overnight.
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